Literature DB >> 24439414

Enhanced reseeding of decellularized rodent lungs with mouse embryonic stem cells.

Shimon Lecht1, Collin T Stabler1, Alexis L Rylander1, Rachel Chiaverelli1, Edward S Schulman2, Cezary Marcinkiewicz1, Peter I Lelkes3.   

Abstract

Repopulation of decellularized lung scaffolds (DLS) is limited due to alterations in the repertoire and ratios of the residual extracellular matrix (ECM) proteins, characterized by e.g., the retention of type I collagen and loss of glycoproteins. We hypothesized that pre-treatment of decellularized matrices with defined ECM proteins, which match the repertoire of integrin receptors expressed by the cells to be seeded (e.g., embryonic stem cells) can increase the efficacy of the reseeding process. To test this hypothesis, we first determined the integrin receptors profile of mouse embryonic stem cells (mESCs). Mouse ESCs express α3, α5, α6, α9 and β1, but not α1, α2 and α4 integrin subunits, as established by Western blotting and adhesion to laminin and fibronectin, but not to collagens type I and IV. Reseeding of DLS with mESCs was inefficient (6.9 ± 0.5%), but was significantly enhanced (2.3 ± 0.1 fold) by pre-treating the scaffolds with media conditioned by A549 human lung adenocarcinoma cells, which we found to contain ∼5 μg/ml laminin. Furthermore, pre-treatment with A549-conditioned media resulted in a significantly more uniform distribution of the seeded mESCs throughout the engineered organ as compared to untreated DLS. Our study may advance whole lung engineering by stressing the importance of matching the integrin receptor repertoire of the seeded cells and the cell binding motifs of DLS.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acellular matrix; Cell adhesion; Embryonic stem cells; Extracellular matrix (ECM); Integrin; Lung

Mesh:

Substances:

Year:  2014        PMID: 24439414      PMCID: PMC5030820          DOI: 10.1016/j.biomaterials.2013.12.093

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  45 in total

1.  Comparative assessment of detergent-based protocols for mouse lung de-cellularization and re-cellularization.

Authors:  John M Wallis; Zachary D Borg; Amanda B Daly; Bin Deng; Bryan A Ballif; Gilman B Allen; Diane M Jaworski; Daniel J Weiss
Journal:  Tissue Eng Part C Methods       Date:  2012-01-26       Impact factor: 3.056

2.  Deposition of inhaled particles in the lungs.

Authors:  Ana Fernández Tena; Pere Casan Clarà
Journal:  Arch Bronconeumol       Date:  2012-03-30       Impact factor: 4.872

3.  Initial binding and recellularization of decellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells.

Authors:  Amanda B Daly; John M Wallis; Zachary D Borg; Ryan W Bonvillain; Bin Deng; Bryan A Ballif; Diane M Jaworski; Gilman B Allen; Daniel J Weiss
Journal:  Tissue Eng Part A       Date:  2011-09-23       Impact factor: 3.845

4.  Heterogeneous mixed-lineage differentiation of mouse embryonic stem cells induced by conditioned media from a549 cells.

Authors:  Shimon Lecht; Jonathan A Gerstenhaber; Collin T Stabler; Pimchanok Pimton; Seda Karamil; Cezary Marcinkiewicz; Edward S Schulman; Peter I Lelkes
Journal:  Stem Cells Dev       Date:  2014-06-03       Impact factor: 3.272

Review 5.  Laminin isoforms and lung development: all isoforms are not equal.

Authors:  Nguyet M Nguyen; Robert M Senior
Journal:  Dev Biol       Date:  2006-04-03       Impact factor: 3.582

6.  Fibroblast engraftment in the decellularized mouse lung occurs via a β1-integrin-dependent, FAK-dependent pathway that is mediated by ERK and opposed by AKT.

Authors:  Huanxing Sun; Elizabeth Calle; Xiaosong Chen; Aditi Mathur; Yangyang Zhu; Julio Mendez; Liping Zhao; Laura Niklason; Xueyan Peng; Hong Peng; Erica L Herzog
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-13       Impact factor: 5.464

7.  Enhanced in vivo function of bioartificial lungs in rats.

Authors:  Jeremy J Song; Sam S Kim; Zhilin Liu; Joren C Madsen; Douglas J Mathisen; Joseph P Vacanti; Harald C Ott
Journal:  Ann Thorac Surg       Date:  2011-09       Impact factor: 4.330

8.  Integrins regulate mouse embryonic stem cell self-renewal.

Authors:  Yohei Hayashi; Miho Kusuda Furue; Tetsuji Okamoto; Kiyoshi Ohnuma; Yasufumi Myoishi; Yasuaki Fukuhara; Takanori Abe; J Denry Sato; Ryu-Ichiro Hata; Makoto Asashima
Journal:  Stem Cells       Date:  2007-08-23       Impact factor: 6.277

9.  Efficient derivation of alveolar type II cells from embryonic stem cells for in vivo application.

Authors:  Blair Roszell; Mark J Mondrinos; Ariel Seaton; Donald M Simons; Sirma H Koutzaki; Guo-Hua Fong; Peter I Lelkes; Christine M Finck
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

10.  Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells.

Authors:  Tatyana A Prokhorova; Kristoffer T G Rigbolt; Pia T Johansen; Jeanette Henningsen; Irina Kratchmarova; Moustapha Kassem; Blagoy Blagoev
Journal:  Mol Cell Proteomics       Date:  2009-01-17       Impact factor: 5.911

View more
  16 in total

Review 1.  Revascularization of decellularized lung scaffolds: principles and progress.

Authors:  Collin T Stabler; Shimon Lecht; Mark J Mondrinos; Ernesto Goulart; Philip Lazarovici; Peter I Lelkes
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-25       Impact factor: 5.464

2.  An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.

Authors:  Daniel J Weiss; Daniel Chambers; Adam Giangreco; Armand Keating; Darrell Kotton; Peter I Lelkes; Darcy E Wagner; Darwin J Prockop
Journal:  Ann Am Thorac Soc       Date:  2015-04

3.  An Official American Thoracic Society Workshop Report 2015. Stem Cells and Cell Therapies in Lung Biology and Diseases.

Authors:  Darcy E Wagner; Wellington V Cardoso; Sarah E Gilpin; Susan Majka; Harald Ott; Scott H Randell; Bernard Thébaud; Thomas Waddell; Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2016-08

4.  Whole-ovary decellularization generates an effective 3D bioscaffold for ovarian bioengineering.

Authors:  Georgia Pennarossa; Matteo Ghiringhelli; Fulvio Gandolfi; Tiziana A L Brevini
Journal:  J Assist Reprod Genet       Date:  2020-05-02       Impact factor: 3.412

5.  Creation of a Bioengineered Ovary: Isolation of Female Germline Stem Cells for the Repopulation of a Decellularized Ovarian Bioscaffold.

Authors:  Georgia Pennarossa; Matteo Ghiringhelli; Fulvio Gandolfi; Tiziana A L Brevini
Journal:  Methods Mol Biol       Date:  2021

6.  Laminin-driven Epac/Rap1 regulation of epithelial barriers on decellularized matrix.

Authors:  Bethany M Young; Keerthana Shankar; Cindy K Tho; Amanda R Pellegrino; Rebecca L Heise
Journal:  Acta Biomater       Date:  2019-10-05       Impact factor: 8.947

7.  Re-endothelialization of rat lung scaffolds through passive, gravity-driven seeding of segment-specific pulmonary endothelial cells.

Authors:  Michelle E Scarritt; Nicholas C Pashos; Jessica M Motherwell; Zachary R Eagle; Brian J Burkett; Ashley N Gregory; Ricardo Mostany; Daniel J Weiss; Diego F Alvarez; Bruce A Bunnell
Journal:  J Tissue Eng Regen Med       Date:  2017-05-07       Impact factor: 3.963

8.  Enhanced Re-Endothelialization of Decellularized Rat Lungs.

Authors:  Collin T Stabler; Luiz C Caires; Mark J Mondrinos; Cezary Marcinkiewicz; Philip Lazarovici; Marla R Wolfson; Peter I Lelkes
Journal:  Tissue Eng Part C Methods       Date:  2016-04-01       Impact factor: 3.056

9.  Engineering de novo assembly of fetal pulmonary organoids.

Authors:  Mark J Mondrinos; Peter L Jones; Christine M Finck; Peter I Lelkes
Journal:  Tissue Eng Part A       Date:  2014-06-25       Impact factor: 3.845

10.  Hypoxia enhances differentiation of mouse embryonic stem cells into definitive endoderm and distal lung cells.

Authors:  Pimchanok Pimton; Shimon Lecht; Collin T Stabler; Gregg Johannes; Edward S Schulman; Peter I Lelkes
Journal:  Stem Cells Dev       Date:  2014-10-27       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.